Loading...
NPI 1558310474 · Springfield, MA · Magnetic Resonance Imaging (MRI) Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Baystate Mri & Imaging Center, LLC is a magnetic resonance imaging (mri) clinic/center provider located in Springfield, Massachusetts. This profile covers 30 Medicare and 18 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Baystate Mri & Imaging Center, LLC |
| Address | 80 Wason Ave. |
| City | Springfield |
| State | MA |
| ZIP | 01107 |
| Taxonomy | Magnetic Resonance Imaging (MRI) Clinic/Center |
| NPI Enumerated | May 8, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $6.7M |
| Medicare | $2.6M |
This facility reports materially larger Medicaid revenue than Medicare revenue, with Total Medicare revenue: $2.6M versus Total Medicaid revenue: $6.7M, indicating Medicaid is the dominant payer by dollars for this provider. The dual-payer presence is meaningful — analysts should treat this as a provider that serves both public programs but with a heavier Medicaid footprint in total revenue terms.
Medicare revenue is highly concentrated in PET and PET radiopharmaceuticals: the precomputed top-3 Medicare codes by revenue account for 57.2% of Medicare revenue and are led by 78815 (33.0% of Medicare revenue), A9595 (13.7%), and A9552 (10.4%). This mix points to an operation with substantial PET/CT oncology activity on its Medicare panel, not just standalone MRI services.
Medicaid revenue concentration skews toward MRI exam volume: the precomputed top-3 Medicaid codes account for 48.3% of Medicaid revenue and are 78815 (22.8% of Medicaid revenue), 70553 (14.1%), and 73721 (11.3%). While PET remains important to Medicaid revenue, the presence of high-volume MRI codes (70553, 73721, 72148) indicates a sizable MRI outpatient practice serving the state Medicaid population.
On Medicare comparisons this provider is an outlier for multiple codes tied to PET and MRI. For example, 78815 ranks #113 of 6566 providers nationally (98th percentile; extreme outlier) and A9552 ranks #32 of 2411 (99th percentile; extreme outlier), while MRI code 72197 ranks #14 of 4732 providers nationally (100th percentile; extreme outlier). These high national percentiles indicate the provider is a major national-volume center for several imaging studies, especially PET/CT oncology scans and contrast-enhanced MRI pelvic exams.
Within Massachusetts Medicaid markets the provider also shows strong statewide positioning on several MRI and PET-related codes. Notably, 73721 ranks #2 of 93 providers in-state (99th percentile; notably above typical state volume), 72148 ranks #5 of 105 (96th percentile; notably above), and 77049 ranks #1 of 10 providers in-state (100th percentile; notably above typical state volume for breast MRI). These ranks support characterization as a leading in-state imaging vendor for musculoskeletal, spine, and breast MRI.
The provider’s code mix includes multiple radiopharmaceuticals and PET tracers across payers — Medicare shows A9595 (Piflufolastat f-18) with 738 claims and A9552 (FDG) with 651 claims, and Medicaid also reports A9552 among its top codes with 2.4K claims. This pattern signals on-site or regularly administered PET tracer services and a substantive oncology imaging focus rather than a pure MRI-only center.
Operational implications from the dual-payer data: Medicare billing is concentrated in higher-reimbursement PET/CT and radiotracer codes while Medicaid volumes emphasize high-frequency MRI studies (brain, spine, extremity, abdominal). Payer-specific product mix suggests the center likely markets both advanced nuclear medicine/PET oncology services and high-throughput MRI exams to different referral networks.
The provider has a long-standing presence in the NPI registry, enumerated on 2006-05-08 (~20 years ago), which aligns with the depth of service lines and the high national/state ranks observed; longevity combined with outlier volumes supports interpretation as an established imaging center with mature PET and MRI workflows.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
30 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 650 | $1,310 | $851.5K |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 740 | $480 | $353.5K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 650 | $410 | $268.9K |
| 72197 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the pelvis first without using contrast and again after injecting contrast material. | 650 | $280 | $180.6K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 110 | $1,330 | $139.2K |
| 70553 | In this procedure, the provider performs a magnetic resonance imaging, or MRI, study of the brain including the brain stem. He performs this procedure without using contrast material. He then follows… | 510 | $260 | $133.6K |
| 72148 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the lumbar spinal canal and contents without using contrast. | 660 | $160 | $102.2K |
| 74183 | The provider performs magnetic resonance imaging of the structures and organs of the abdomen, initially without control and then with additional sequences after injection of contrast. | 290 | $290 | $83.8K |
| 73721 | In this diagnostic procedure, the provider performs magnetic resonance imaging of a lower extremity joint without using contrast material. | 400 | $170 | $66.5K |
| 73221 | In this diagnostic procedure, the provider performs a magnetic resonance imaging, or MRI imaging, of any of the joints of a patient’s upper extremity, which can be the shoulder, elbow, wrist, or… | 340 | $160 | $54.2K |
Showing 1–10 of 30
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 30 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
30 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| A9595 | 5 | 20 | 410 | $490 | $257.6K |
| A9552 | 5 | 40 | 210 | $410 | $104.7K |
| 78815 | 8 | 160 | 70 | $580 | $94.4K |
| A9596 | 4 | 10 | 60 | $820 | $65.8K |
| A9587 | 3 | 10 | 1,160 | $40 | $49.9K |
| 78816 | 9 | 60 | 20 | $510 | $29.1K |
| 70553 | 8 | 330 | 70 | $130 | $14.8K |
| 74183 | 11 | 280 | 50 | $140 | $12.3K |
| 72197 | 1 | 190 | 40 | $150 | $9.9K |
| 72148 | 5 | 400 | 60 | $90 | $9K |
Showing 1–10 of 30
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
18 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 2,730 | $560 | $1.5M |
| 70553 | In this procedure, the provider performs a magnetic resonance imaging, or MRI, study of the brain including the brain stem. He performs this procedure without using contrast material. He then follows… | 3,590 | $260 | $947.2K |
| 73721 | In this diagnostic procedure, the provider performs magnetic resonance imaging of a lower extremity joint without using contrast material. | 3,740 | $200 | $759.4K |
| 72148 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the lumbar spinal canal and contents without using contrast. | 4,040 | $170 | $670K |
| 72197 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the pelvis first without using contrast and again after injecting contrast material. | 1,900 | $310 | $592.8K |
| 73221 | In this diagnostic procedure, the provider performs a magnetic resonance imaging, or MRI imaging, of any of the joints of a patient’s upper extremity, which can be the shoulder, elbow, wrist, or… | 2,510 | $180 | $438.9K |
| 74183 | The provider performs magnetic resonance imaging of the structures and organs of the abdomen, initially without control and then with additional sequences after injection of contrast. | 1,650 | $250 | $414.5K |
| 72141 | In this diagnostic procedure, the provider performs a magnetic resonance imaging (MRI) study of the cervical spinal canal and contents without using contrast material. | 2,160 | $150 | $332.2K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2,440 | $130 | $306.9K |
| 70551 | The provider uses magnetic resonance imaging, or MRI, to examine the brain and brain stem. The provider does not administer contrast for this exam. | 1,710 | $160 | $280.9K |
Showing 1–10 of 18
How this provider's Medicaid billing volume and revenue compare to other Massachusetts providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Massachusetts median
18 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 7 | 50 | 630 | $460 | $459.9K |
| 70553 | In this procedure, the provider performs a magnetic resonance imaging, or MRI, study of the brain including the brain stem. He performs this procedure without using contrast material. He then follows… | 15 | 110 | 310 | $210 | $331K |
| 70551 | The provider uses magnetic resonance imaging, or MRI, to examine the brain and brain stem. The provider does not administer contrast for this exam. | 29 | 110 | 340 | $160 | $211.7K |
| 72148 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the lumbar spinal canal and contents without using contrast. | 5 | 110 | 660 | $140 | $176.7K |
| 74183 | The provider performs magnetic resonance imaging of the structures and organs of the abdomen, initially without control and then with additional sequences after injection of contrast. | 11 | 60 | 150 | $200 | $160.7K |
| 73721 | In this diagnostic procedure, the provider performs magnetic resonance imaging of a lower extremity joint without using contrast material. | 2 | 90 | 280 | $180 | $152.9K |
| 72197 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the pelvis first without using contrast and again after injecting contrast material. | 4 | 30 | 130 | $250 | $142.8K |
| 72141 | In this diagnostic procedure, the provider performs a magnetic resonance imaging (MRI) study of the cervical spinal canal and contents without using contrast material. | 6 | 80 | 260 | $150 | $94.1K |
| 73221 | In this diagnostic procedure, the provider performs a magnetic resonance imaging, or MRI imaging, of any of the joints of a patient’s upper extremity, which can be the shoulder, elbow, wrist, or… | 3 | 60 | 230 | $160 | $86.5K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 6 | 30 | 710 | $70 | $70.5K |
Showing 1–10 of 18
Other providers in the same ZIP code as Baystate Mri & Imaging Center, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Center For Human Development, Inc. | MA | Community/Behavioral Health Agency | $0 | $97.1M |
| Viecare Corp | MA | Foster Care Agency | $0 | $35.5M |
| Andventure, LLC | MA | Home Health Agency | $0 | $14.6M |
| Radiology & Imaging, Inc. | MA | Diagnostic Radiology Physician | $0 | $5.8M |
| David Lally | MA | Ophthalmology Physician | $3.2M | $670 |
| Rebecca Soares | MA | Retina Specialist (Ophthalmology) Physician | $3M | $9.1K |
| Shilpa Gulati | MA | Ophthalmology Physician | $2.4M | $0 |
| Andrew Lam | MA | Ophthalmology Physician | $1.4M | $0 |
| Hari Mylvaganam | MA | Ophthalmology Physician | $1.3M | $5.1K |
| Pioneer Valley Surgicenter LLC | MA | Ambulatory Surgical Clinic/Center | $429.2K | $614.8K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.